RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Please provide your email address to receive an email when new articles are posted on . Ortho Clinical Diagnostics received FDA clearance for Ortho Vision Max, a fully automated blood analyzer ...
New Menu Capability Now Available on VISION and VISION MAX Analyzers Increases Confidence in Blood Transfusion-Related Test Results RARITAN, N.J., Sept. 27, 2021 /PRNewswire/ -- Ortho Clinical ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Back to Healio Ortho Clinical Diagnostics announced it ...
Raritan-based Ortho Clinical Diagnostics is expected to reap a windfall if it goes public, possibly by year’s end, but for now CEO Martin Madaus is focused on managing growth to date.Raritan-based ...
RARITAN, N.J., June 7, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results